The transcriptional mechanisms regulated by NR4A2 alter cholesterol metabolism, leading to an alternatively activated phenotype in CD8+ T cells and impaired antigen presentation capability within GBM (Ye et al., 2023). The gene discussed is NR4A2; the disease is glioblastoma.